116 related articles for article (PubMed ID: 10504120)
1. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa.
Andersson S; Thorstensson R; Ramirez KG; Krook A; von Sydow M; Dias F; Biberfeld G
Transfusion; 1999 Aug; 39(8):845-51. PubMed ID: 10504120
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.
Gallo D; Diggs JL; Hanson CV
J Clin Microbiol; 1994 Sep; 32(9):2046-9. PubMed ID: 7814523
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
Malm K; Kjerstadius T; Andersson S
J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.
Flanagan P; McAlpine L; Ramskill SJ; Smith AG; Eglin R; Parry JV; Mortimer PP
Vox Sang; 1995; 68(4):220-4. PubMed ID: 7660640
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.
Liu H; Shah M; Stramer SL; Chen W; Weiblen BJ; Murphy EL
Transfusion; 1999; 39(11-12):1185-93. PubMed ID: 10604244
[TBL] [Abstract][Full Text] [Related]
6. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new generation synthetic peptide combination assay for detection of antibodies to HIV-1, HIV-2, HTLV-I, and HTLV-II simultaneously.
Zhang X; Constantine NT; Bansal J; Callahan JD; Marsiglia VC
J Med Virol; 1992 Sep; 38(1):49-53. PubMed ID: 1357083
[TBL] [Abstract][Full Text] [Related]
8. Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II.
Andersson S; Gessain A; Taylor GP
Virus Res; 2001 Oct; 78(1-2):101-6. PubMed ID: 11520584
[TBL] [Abstract][Full Text] [Related]
9. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
10. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
Lal RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
[TBL] [Abstract][Full Text] [Related]
11. HTLV infection in ELISA-negative blood donors.
Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
[TBL] [Abstract][Full Text] [Related]
12. Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil.
da Silva Brito V; Santos FLN; Gonçalves NLS; Araujo THA; Nascimento DSV; Pereira FM; Boa-Sorte NCA; Grassi MFR; Caterino-de-Araujo A; Galvão-Castro B
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232131
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
14. Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays.
Lee HH; Shih J; O'Donnell D; Swanson P; Mann T; Allain JP
Clin Diagn Virol; 1997 May; 8(1):9-16. PubMed ID: 9248654
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.
Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB
AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
Dalekos GN; Zervou E; Karabini F; Elisaf M; Bourantas K; Siamopoulos KC
Transfusion; 1995 Jun; 35(6):503-6. PubMed ID: 7770902
[TBL] [Abstract][Full Text] [Related]
17. HTLV-I/II infection among immigrants to Spain.
Vallejo A; Gutiérrez M; Soriano V
Vox Sang; 1994; 67(1):79-80. PubMed ID: 7975460
[No Abstract] [Full Text] [Related]
18. [Detection of antibodies against T-cell lymphotropic virus HTLV-I/II in Cuban patients with chronic renal failure undergoing hemodialysis].
Rivero RA; Hernández P; Suárez O; Hidalgo-Gato R; Navea LM; Yamaguchi K; Ballester JM
Sangre (Barc); 1992 Jun; 37(3):205-6. PubMed ID: 1359655
[No Abstract] [Full Text] [Related]
19. Strategies for diagnosis of HTLV-I and -II.
Thorstensson R; Albert J; Andersson S
Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
[TBL] [Abstract][Full Text] [Related]
20. Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populations.
Tosswill JH; Parry JV; Weber JN
J Med Virol; 1992 Mar; 36(3):167-71. PubMed ID: 1348782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
